Table II. Comparison of clinicopathological characteristics between patients with negative and positive TAP1 and DLL4 expression in patients with pStage II/III gastric cancer (GC).

TAP1: Transporter associated with antigen processing 1; DLL4: Delta-like 4. Bold values indicate statistical significance.